ABIONYX PHARMA: cashflow_financing
| Value | {"amount": 3425000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | ABIONYX PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T22:42:18.659153+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/076a17fa-bd0c-48b5-9336-4773005b29f6
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500785J7VIC5YPC96:2025-12-31Retrieved: 2026-08-23T22:42:18.659153+02:00
Raw response sha256:
df7f82c289c957874561346a37c93090…Cite as: FACTANKER, https://factanker.com/fact/076a17fa-bd0c-48b5-9336-4773005b29f6
History
- no predecessors — first report